Tamthom Ngo Truong

Array ( [id] => 263799 [patent_doc_number] => 07569564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Cyclothiocarbamate derivatives as progesterone receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/351002 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28579 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569564.pdf [firstpage_image] =>[orig_patent_app_number] => 11351002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760738 [patent_doc_number] => 20060211683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Erastin and erastin binding proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/340430 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 40382 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211683.pdf [firstpage_image] =>[orig_patent_app_number] => 11340430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866092 [patent_doc_number] => 20060100223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Quinazoline derivatives and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 11/313304 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10379 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100223.pdf [firstpage_image] =>[orig_patent_app_number] => 11313304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122221 [patent_doc_number] => 07709640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 11/313289 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14052 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709640.pdf [firstpage_image] =>[orig_patent_app_number] => 11313289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572840 [patent_doc_number] => 07829566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => '4-amino-quinazolines' [patent_app_type] => utility [patent_app_number] => 11/300626 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17499 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829566.pdf [firstpage_image] =>[orig_patent_app_number] => 11300626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875562 [patent_doc_number] => 20060167105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'CCR-3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/298241 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10811 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167105.pdf [firstpage_image] =>[orig_patent_app_number] => 11298241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341670 [patent_doc_number] => 07501428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Quinazoline thiazolinones' [patent_app_type] => utility [patent_app_number] => 11/244028 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9971 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501428.pdf [firstpage_image] =>[orig_patent_app_number] => 11244028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694788 [patent_doc_number] => 20060154935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Quinazolines useful as modulators of ion channels' [patent_app_type] => utility [patent_app_number] => 11/216899 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35308 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154935.pdf [firstpage_image] =>[orig_patent_app_number] => 11216899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92547 [patent_doc_number] => 07737274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof' [patent_app_type] => utility [patent_app_number] => 11/207751 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12070 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737274.pdf [firstpage_image] =>[orig_patent_app_number] => 11207751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274296 [patent_doc_number] => 07560461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Quinazoline derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/210028 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7026 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560461.pdf [firstpage_image] =>[orig_patent_app_number] => 11210028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829123 [patent_doc_number] => 20060063770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Nitrogenous heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/200456 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5752 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063770.pdf [firstpage_image] =>[orig_patent_app_number] => 11200456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467929 [patent_doc_number] => 07235575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Guanidine mimics as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/197978 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51654 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235575.pdf [firstpage_image] =>[orig_patent_app_number] => 11197978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131880 [patent_doc_number] => 07700608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Quinazoline derivatives and their use in the treatment of thrombocythemia' [patent_app_type] => utility [patent_app_number] => 11/197775 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5462 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700608.pdf [firstpage_image] =>[orig_patent_app_number] => 11197775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821117 [patent_doc_number] => 20060025430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis' [patent_app_type] => utility [patent_app_number] => 11/185698 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25795 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025430.pdf [firstpage_image] =>[orig_patent_app_number] => 11185698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821093 [patent_doc_number] => 20060025406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Modulators of hepatocyte growth factor/c- Met activity' [patent_app_type] => utility [patent_app_number] => 11/175896 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32613 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025406.pdf [firstpage_image] =>[orig_patent_app_number] => 11175896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895478 [patent_doc_number] => 20060004017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Quinazoline derivatives as angiogenesis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/169122 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128128 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004017.pdf [firstpage_image] =>[orig_patent_app_number] => 11169122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820630 [patent_doc_number] => 07407963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof' [patent_app_type] => utility [patent_app_number] => 11/169078 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11801 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407963.pdf [firstpage_image] =>[orig_patent_app_number] => 11169078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966433 [patent_doc_number] => 07939538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases' [patent_app_type] => utility [patent_app_number] => 11/168005 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20418 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939538.pdf [firstpage_image] =>[orig_patent_app_number] => 11168005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821114 [patent_doc_number] => 20060025427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/167950 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11877 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025427.pdf [firstpage_image] =>[orig_patent_app_number] => 11167950 [rel_patent_id] =>[rel_patent_doc_number] =>)